(Q95596348)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30102222%20AND%20SRC:MED&resulttype=core&format=json

27 May 2020

title

[177Lu]-PSMA-617 radionuclide therapy in patients with metastatic castration-resistant prostate cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30102222%20AND%20SRC:MED&resulttype=core&format=json

27 May 2020

author name string

Thorsten Derlin

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30102222%20AND%20SRC:MED&resulttype=core&format=json

27 May 2020

Sebastian Schmuck

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30102222%20AND%20SRC:MED&resulttype=core&format=json

27 May 2020

publication date

1 August 2018

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30102222%20AND%20SRC:MED&resulttype=core&format=json

Lancet Oncology Commission

27 May 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30102222%20AND%20SRC:MED&resulttype=core&format=json

27 May 2020

volume

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30102222%20AND%20SRC:MED&resulttype=core&format=json

27 May 2020

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30102222%20AND%20SRC:MED&resulttype=core&format=json

27 May 2020

page(s)

e372

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30102222%20AND%20SRC:MED&resulttype=core&format=json

[177Lu]-PSMA-617 radionuclide treatment in patients with metastatic castration-resistant prostate cancer (LuPSMA trial): a single-centre, single-arm, phase 2 study

27 May 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2818%2930488-1

7 January 2021

German Multicenter Study Investigating 177Lu-PSMA-617 Radioligand Therapy in Advanced Prostate Cancer Patients

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2818%2930488-1

7 January 2021

Phase 3 Trial of 177Lu-Dotatate for Midgut Neuroendocrine Tumors.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2818%2930488-1

7 January 2021

Baseline 18F-FDG PET/CT parameters as imaging biomarkers of overall survival in castrate-resistant metastatic prostate cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2818%2930488-1

7 January 2021

High level PSMA expression is associated with early PSA recurrence in surgically treated prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2818%2930488-1

7 January 2021

10.1016/S1470-2045(18)30488-1

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30102222%20AND%20SRC:MED&resulttype=core&format=json

27 May 2020

1 reference